Tietueen sitaatit

APA-viite (7. p.)
Lu, R., Jin, Y., & Zheng, M. (2025). USP5‐dependent HDAC1 promotes cisplatin resistance and the malignant progression of non–small cell lung cancer by regulating RILP acetylation levels. Wiley.
Chicago-viite (17. p.)
Lu, Rongguo, Yulin Jin, ja Mingfeng Zheng. USP5‐dependent HDAC1 Promotes Cisplatin Resistance and the Malignant Progression of Non–small Cell Lung Cancer by Regulating RILP Acetylation Levels. Wiley, 2025.
MLA-viite (9. p.)
Lu, Rongguo, et al. USP5‐dependent HDAC1 Promotes Cisplatin Resistance and the Malignant Progression of Non–small Cell Lung Cancer by Regulating RILP Acetylation Levels. Wiley, 2025.
Varoitus: Nämä viitteet eivät aina ole täysin luotettavia.